This email is issued by Braincare Limited and has been approved as a financial promotion for the purposes of s.21 of the Financial Services and Markets Act 2000 by Prosper Capital LLP which is authorised and regulated by the Financial Conduct Authority with firm reference number 453007 on 26th September 2024.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
© 2024 Heights. 27 Old Gloucester Street London, WC1N 3AX
|